KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Synopsys (SNPS) Research & Development (2016 - 2025)

Historic Research & Development for Synopsys (SNPS) over the last 17 years, with Q4 2025 value amounting to $746.8 million.

  • Synopsys' Research & Development rose 3461.03% to $746.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $2.5 billion, marking a year-over-year increase of 1906.39%. This contributed to the annual value of $2.5 billion for FY2025, which is 1906.39% up from last year.
  • According to the latest figures from Q4 2025, Synopsys' Research & Development is $746.8 million, which was up 3461.03% from $625.3 million recorded in Q3 2025.
  • Synopsys' Research & Development's 5-year high stood at $746.8 million during Q4 2025, with a 5-year trough of $357.5 million in Q1 2021.
  • Its 5-year average for Research & Development is $476.6 million, with a median of $465.6 million in 2023.
  • Its Research & Development has fluctuated over the past 5 years, first plummeted by 1033.65% in 2022, then skyrocketed by 3461.03% in 2025.
  • Quarter analysis of 5 years shows Synopsys' Research & Development stood at $413.9 million in 2021, then decreased by 10.34% to $371.1 million in 2022, then grew by 25.53% to $465.8 million in 2023, then rose by 19.11% to $554.8 million in 2024, then skyrocketed by 34.61% to $746.8 million in 2025.
  • Its last three reported values are $746.8 million in Q4 2025, $625.3 million for Q3 2025, and $554.0 million during Q2 2025.